Healthy adult
Conditions
Interventions
Sponsors
EP Mediate Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1)Males and females from 18 to 64 years of age (2)Subject who did have cold like symptoms in winter within 2 years (3)Subjects will be selected cold like symptoms during pre-treatment observation period and result of a preliminary examination (4)Subjects who can agree in writing to participate in the study
Exclusion criteria
Exclusion criteria: (1)Subjects who have disease requiring medication, and treatment except dry eye and cavity protection, or have a history of serious treatment (2)Subjects having the disease past medical history that needed a diet and exercise therapy under the management of the doctor (3)Subjects who having atopic dermatitis, bronchial asthma, and chronic bronchitis (4)Subjects who take antiallergic drugs (5)Subjects who cannot restrict the use of medicines or health foods that may influence this study after informed consent (6)Subjects who vaccinated influenza or the corona vaccine within four weeks on preliminary examination and hope for vaccination during an intake period (7)Heavy drinkers of alcohol (8)Heavy excessive smokers (9)Subjects who are planning to travel abroad during the study period, or who are planning of overseas business trip (10)Subjects who are becoming pregnant and lactating or intend to become pregnant (11)Night and day shift worker (12)Subjects who have participated in other clinical studies within one month before giving consent or plan to participate during the present study period (13)Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire (14)Subjects who are judged as unsuitable for the study based on the results of clinical examination or cardiopulmonary abnormality in the past (15)Subjects having possibilities for emerging allergy relates to the study (16)Subjects who are judges as unsuitable for the study bases on the result of clinical and physical examination on preliminary examination (17)Subjects who are judged as unsuitable for the study by the investigator for other reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| (1)Cumulative score with cold symptoms (2)Cumulative days with cold symptoms | — |
Secondary
| Measure | Time frame |
|---|---|
| (1)average score with cold symptoms (2)pDC activity (MFI of CD86, HLA-DR, CD40 and CD80) in the peripheral blood (3)NK activity | — |
Countries
Japan
Contacts
Public ContactTamaki Furuhata
EP Mediate Co., Ltd. Foods Department, Trial Planning Section 1
Outcome results
None listed